Evidence map›Paper›PMID 28315134›Full record

Trial reportJournal of genetic counseling2017

Reasons for Declining Preconception Expanded Carrier Screening Using Genome Sequencing.

Marian J Gilmore, Jennifer Schneider, James V Davis, Tia L Kauffman, Michael C Leo, Kellene Bergen, Jacob A Reiss, Patricia Himes, Elissa Morris, Carol Young and 3 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of genetic counseling, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Prevalence and predictors of medical information avoidance: a systematic review and meta-analysis.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2025
    Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Marian J GilmoreDepartment of Medical Genetics, Kaiser Permanente Northwest, Portland, OR, USA. marian.j.gilmore@kp.org.
Jennifer SchneiderCenter for Health Research, Kaiser Permanente Northwest, Portland, OR, USA.
James V DavisCenter for Health Research, Kaiser Permanente Northwest, Portland, OR, USA.
Tia L KauffmanCenter for Health Research, Kaiser Permanente Northwest, Portland, OR, USA.
Michael C LeoCenter for Health Research, Kaiser Permanente Northwest, Portland, OR, USA.
Kellene BergenCenter for Health Research, Kaiser Permanente Northwest, Portland, OR, USA.
Jacob A ReissCenter for Health Research, Kaiser Permanente Northwest, Portland, OR, USA.
Patricia HimesDepartment of Medical Genetics, Kaiser Permanente Northwest, Portland, OR, USA.
Elissa MorrisDepartment of Medical Genetics, Kaiser Permanente Northwest, Portland, OR, USA.
Carol YoungCenter for Health Research, Kaiser Permanente Northwest, Portland, OR, USA.
Carmit McMullenCenter for Health Research, Kaiser Permanente Northwest, Portland, OR, USA.
Benjamin S WilfondTreuman Katz Center for Pediatric Bioethics, Seattle Children's Research Institute, Seattle, WA, USA.
Katrina A B GoddardCenter for Health Research, Kaiser Permanente Northwest, Portland, OR, USA.

Funding

Clinical Implementation of Carrier Testing using NGSUM1HG007292 · NHGRI · KAISER FOUNDATION RESEARCH INSTITUTE · PI GODDARD, KATRINA A., WILFOND, BENJAMIN SIMON · 2013 to 2016
$8.2M
CSER RoRC Centralized Support Coordinating CenterU01HG007307 · NHGRI · UNIVERSITY OF WASHINGTON · PI BURKE, WYLIE G., JARVIK, GAIL PAIRITZ · 2013 to 2016
$3.6M
National Human Genome Research Institute U01HG007307National Human Genome Research Institute UM1HG007292NHGRI NIH HHS U01 HG007307NHGRI NIH HHS UM1 HG007292
6 · The paper itself

Abstract

Genomic carrier screening can identify more disease-associated variants than existing carrier screening methodologies, but its utility from patients' perspective is not yet established. A randomized controlled trial for preconception genomic carrier screening provided an opportunity to understand patients' decisions about whether to accept or decline testing. We administered a survey to potential genomic carrier screening recipients who declined participation (N = 240) to evaluate their reasons for doing so. Two thirds of women declined participation. We identified major themes describing reasons these individuals declined to participate; the most common were time limitation, lack of interest, not wanting to know the information, and potential cause of worry or anxiety. Most women eligible for genomic carrier screening indicated that their reasons for opting out were due to logistical issues rather than opposing the rationale for testing. As expanded carrier screening and genomic sequencing become a more routine part of clinical care, it is anticipated there will be variable uptake from individuals for this testing. Thus, the advancement of clinical carrier screening from single genes, to expanded screening panels, to an exome- or genome-wide platform, will require approaches that respect individual choice to receive genetic testing for reproductive risk assessment.

Indexed as

AdultDecision MakingFamily Planning ServicesFemaleGenetic Carrier ScreeningGenetic CounselingGenetic TestingHumansMalePreconception CareSurveys and QuestionnairesDeclining genetic testingGenome sequencingGenomic medicinePatient testing decisionsPreconception expanded carrier screeningQualitative researchReproductive decisions

Identifiers

PMID28315134
PMCPMC5601030

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.